CVE-2019-19679

CVE-2019-19679 is a medium-severity vulnerability in Xpand-it Xray Test Mangaement with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

In "Xray Test Management for Jira" prior to version 3.5.5, remote authenticated attackers can cause XSS in the Pre-Condition Summary entry point via the summary field of a Create Pre-Condition action for a new Test Issue.

Frequently asked questions

What is CVE-2019-19679?
In "Xray Test Management for Jira" prior to version 3.5.5, remote authenticated attackers can cause XSS in the Pre-Condition Summary entry point via the summary field of a Create Pre-Condition action for a new Test Issue.
How severe is CVE-2019-19679?
CVE-2019-19679 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2019-19679 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (46th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2019-19679?
CVE-2019-19679 affects Xpand-it Xray Test Mangaement. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2019-19679?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2019-19679 published?
CVE-2019-19679 was published on 2019-12-09 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Xpand-it Xray Test Mangaement

All CVEs affecting Xpand-it Xray Test Mangaement →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →